Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study.

Filiaciones

Martin-Moreno PL:

Nephrology Department, Clínica Universidad de Navarra, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

Sánchez-Fructuoso AI:

Nephrology Department, Hospital Clínico Universitario San Carlos, Madrid, Spain

Mazuecos A:

Nephrology Department, Hospital Puerta del Mar, Cádiz, Spain

Mir M:

Nephrology Department, Hospital del Mar, Barcelona, Spain

Lopez-Lopez I:

Nephrology Department, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain

González-Rinne A:

Nephrology Department, Hospital Universitario de Canarias, Instituto de Tecnologías Biomédicas (ITB)-Universidad de La Laguna, Tenerife, Spain

Coca A:

Nephrology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain

Valero R:

Nephrology Department, H.U. Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, Spain

Ventura Galiano A:

Kidney Transplant Unit, Hospital Universitari i Politécnic La Fe, Valencia, Spain

Ridao N:

Nephrology Department, Hospital Universitario Central de Asturias, Oviedo, Spain

Toapanta-Gaibor NG:

Nephrology Department, Hospital Vall d'Hebron, Barcelona, Spain

Fernández-Tagarro E:

Nephrology Department, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas, Spain

Cruzado-Vega L:

Nephrology Department, Hospital General Universitario de Elche, Elche, Spain

Pérez-Mir M:

Kidney Transplant Unit, Nephrology Department, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain

Jiménez C:

Nephrology Department, Hospital Universitario La Paz, Madrid, Spain